Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)

OBJECTIVE: Osteopontin (OPN) is an extracellular matrix protein that plays an integral role in myocardial remodelling and has previously been shown to be a valuable biomarker in cardiovascular disease. Because of the concentric myocardial hypertrophy associated with severe, symptomatic aortic stenos...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Heart
Autori principali: Lutz, Matthias, von Ingersleben, Nora, Lambers, Moritz, Rosenberg, Mark, Freitag-Wolf, Sandra, Dempfle, Astrid, Lutter, Georg, Frank, Johanne, Bramlage, Peter, Frey, Norbert, Frank, Derk
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2017
Soggetti:
Valvular Heart Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5515168/
https://ncbi.nlm.nih.gov/pubmed/28761684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2017-000633
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi